Download PDF
Semin intervent Radiol 2022; 39(03): 275-284
DOI: 10.1055/s-0042-1754349
Review Article

Treating Recurrent Pleural Disease: A Review of Indications and Technique for Chemical Pleurodesis for the Interventional Radiologist

Surbhi B. Trivedi
1   Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
,
Matthew Niemeyer
1   Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Pleural space diseases such as recurrent pleural effusion and pneumothorax inflict a significant symptomatic burden on patients. Guidelines and studies are available to guide best practices in the setting of refractory effusions, mostly in the setting of malignancy, and recurrent pneumothorax. Less data is available to guide management of refractory transudative effusions. Recurrent pleural effusions can be treated with tunneled pleural catheters or catheter-based pleurodesis. While refractory transudative effusions can benefit from tunneled pleural catheter, this is an area of ongoing research. Regarding recurrent pneumothorax, video-assisted thoracoscopic surgery (VATS) pleurodesis using mechanical or laser/argon beam coagulation is the most effective means of preventing recurrence. Catheter based pleurodesis, a less invasive means of administering chemical sclerosant via percutaneous thoracostomy tube, is only used when surgery is not an option. However, both approaches induce inflammation of the pleural space, resulting in adherence of the parietal and visceral pleura to prevent fluid or air re-accumulation. This article will discuss catheter based chemical pleurodesis geared toward the interventional radiologist, including a review of disease processes and indications, technique, and strategies to mitigate complications as well as a literature review comparing percutaneous chemical pleurodesis to other therapies.

Keywords

talc pleurodesis - tunneled pleural catheter - malignant effusion - spontaneous pneumothorax - interventional radiology


Publication History

Article published online:
31 August 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Mierzejewski M, Korczynski P, Krenke R, Janssen JP. Chemical pleurodesis - a review of mechanisms involved in pleural space obliteration. Respir Res 2019; 20 (01) 247
    CrossrefPubMedSearch in Google Scholar
  • 2 Miserocchi G. Physiology and pathophysiology of pleural fluid turnover. Eur Respir J 1997; 10 (01) 219-225
    CrossrefPubMedSearch in Google Scholar
  • 3 Saguil A, Wyrick K, Hallgren J. Diagnostic approach to pleural effusion. Am Fam Physician 2014; 90 (02) 99-104
    PubMedSearch in Google Scholar
  • 4 Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician 2006; 73 (07) 1211-1220
    PubMedSearch in Google Scholar
  • 5 Chaaban T, Kanj N, Bou Akl I. Hepatic Hydrothorax: An Updated Review on a Challenging Disease. Lung 2019; 197 (04) 399-405
    CrossrefPubMedSearch in Google Scholar
  • 6 Freeman RK, Ascioti AJ, Dake M, Mahidhara RS. A propensity-matched comparison of pleurodesis or tunneled pleural catheter for heart failure patients with recurrent pleural effusion. Ann Thorac Surg 2014; 97 (06) 1872-1876 , discussion 1876–1877
    CrossrefPubMedSearch in Google Scholar
  • 7 Glazer M, Berkman N, Lafair JS, Kramer MR. Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion. Chest 2000; 117 (05) 1404-1409
    CrossrefPubMedSearch in Google Scholar
  • 8 Hou F, Qi X, Guo X. Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis. Dig Dis Sci 2016; 61 (11) 3321-3334
    CrossrefPubMedSearch in Google Scholar
  • 9 Milanez de Campos JR, Filho LO, de Campos Werebe E. et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest 2000; 118 (01) 13-17
    CrossrefPubMedSearch in Google Scholar
  • 10 Majid A, Kheir F, Fashjian M. et al. Tunneled Pleural Catheter Placement with and without Talc Poudrage for Treatment of Pleural Effusions Due to Congestive Heart Failure. Ann Am Thorac Soc 2016; 13 (02) 212-216
    CrossrefPubMedSearch in Google Scholar
  • 11 Srour N, Potechin R, Amjadi K. Use of indwelling pleural catheters for cardiogenic pleural effusions. Chest 2013; 144 (05) 1603-1608
    CrossrefPubMedSearch in Google Scholar
  • 12 Tremblay A, Mason C, Michaud G. Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J 2007; 30 (04) 759-762
    CrossrefPubMedSearch in Google Scholar
  • 13 Chalhoub M, Saqib A, Castellano M. Indwelling pleural catheters: complications and management strategies. J Thorac Dis 2018; 10 (07) 4659-4666
    CrossrefPubMedSearch in Google Scholar
  • 14 Chambers DM, Abaid B, Gauhar U. Indwelling Pleural Catheters for Nonmalignant Effusions: Evidence-Based Answers to Clinical Concerns. Am J Med Sci 2017; 354 (03) 230-235
    CrossrefPubMedSearch in Google Scholar
  • 15 Light RW. Clinical practice. Pleural effusion. N Engl J Med 2002; 346 (25) 1971-1977
    CrossrefPubMedSearch in Google Scholar
  • 16 Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis 2007; 45 (11) 1480-1486
    CrossrefPubMedSearch in Google Scholar
  • 17 Feller-Kopman DJ, Reddy CB, DeCamp MM. et al. Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline. Am J Respir Crit Care Med 2018; 198 (07) 839-849
    CrossrefPubMedSearch in Google Scholar
  • 18 Herrera Lara S, Fernández-Fabrellas E, Juan Samper G. et al. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters. Lung 2017; 195 (05) 653-660
    CrossrefPubMedSearch in Google Scholar
  • 19 Thomas JM, Musani AI. Malignant pleural effusions: a review. Clin Chest Med 2013; 34 (03) 459-471
    CrossrefPubMedSearch in Google Scholar
  • 20 Taghizadeh N, Fortin M, Tremblay A. US Hospitalizations for Malignant Pleural Effusions: Data From the 2012 National Inpatient Sample. Chest 2017; 151 (04) 845-854
    CrossrefPubMedSearch in Google Scholar
  • 21 Zamboni MM, da Silva Jr CT, Baretta R, Cunha ET, Cardoso GP. Important prognostic factors for survival in patients with malignant pleural effusion. BMC Pulm Med 2015; 15: 29
    CrossrefPubMedSearch in Google Scholar
  • 22 Porcel JM. Malignant pleural effusions because of lung cancer. Curr Opin Pulm Med 2016; 22 (04) 356-361
    CrossrefPubMedSearch in Google Scholar
  • 23 Sabur NF, Chee A, Stather DR. et al. The impact of tunneled pleural catheters on the quality of life of patients with malignant pleural effusions. Respiration 2013; 85 (01) 36-42
    CrossrefPubMedSearch in Google Scholar
  • 24 Bibby AC, Dorn P, Psallidas I. et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur Respir J 2018; 52 (01) 1800349
    CrossrefPubMedSearch in Google Scholar
  • 25 Sahn SA. Malignant pleural effusions. Clin Chest Med 1985; 6 (01) 113-125
    CrossrefPubMedSearch in Google Scholar
  • 26 Boshuizen RC, Vd Noort V, Burgers JA. et al. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). Lung Cancer 2017; 108: 9-14
    CrossrefPubMedSearch in Google Scholar
  • 27 Putnam Jr JB, Light RW, Rodriguez RM. et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999; 86 (10) 1992-1999
    CrossrefPubMedSearch in Google Scholar
  • 28 Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl. 02) ii32-ii40
    CrossrefPubMedSearch in Google Scholar
  • 29 Davies HE, Mishra EK, Kahan BC. et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 2012; 307 (22) 2383-2389
    CrossrefPubMedSearch in Google Scholar
  • 30 Wang L, Deng H, Chen X. et al. Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials. World J Surg Oncol 2020; 18 (01) 184
    CrossrefPubMedSearch in Google Scholar
  • 31 Yeung M, Loh EW, Tiong TY, Tam KW. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis. Clin Exp Metastasis 2020; 37 (04) 541-549
    CrossrefPubMedSearch in Google Scholar
  • 32 Iyer NP, Reddy CB, Wahidi MM. et al. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis. Ann Am Thorac Soc 2019; 16 (01) 124-131
    CrossrefPubMedSearch in Google Scholar
  • 33 Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer 1974; 33 (04) 916-922
    CrossrefPubMedSearch in Google Scholar
  • 34 Petrov D, Mihalova T, Valchev D. Malignant pleural effusions and trapped lung. AME Med J 2020; 5 (00)
    CrossrefPubMedSearch in Google Scholar
  • 35 Dresler CM, Olak J, Herndon II JE. et al; Cooperative Groups Cancer and Leukemia Group B, Eastern Cooperative Oncology Group, North Central Cooperative Oncology Group, Radiation Therapy Oncology Group. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005; 127 (03) 909-915
    CrossrefPubMedSearch in Google Scholar
  • 36 Terra RM, Junqueira JJM, Teixeira LR, Vargas FS, Pêgo-Fernandes PM, Jatene FB. Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?. Chest 2009; 136 (02) 361-368
    CrossrefPubMedSearch in Google Scholar
  • 37 Yim AP, Chan AT, Lee TW, Wan IY, Ho JK. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996; 62 (06) 1655-1658
    CrossrefPubMedSearch in Google Scholar
  • 38 Bhatnagar R, Piotrowska HEG, Laskawiec-Szkonter M. et al. Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial. JAMA 2020; 323 (01) 60-69
    CrossrefPubMedSearch in Google Scholar
  • 39 Kuzdzał J, Sładek K, Wasowski D. et al. Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial. Med Sci Monit 2003; 9 (06) PI54-PI59
    PubMedSearch in Google Scholar
  • 40 Hsia D, Musani AI. Management options for the complicated pleural space. Curr Respir Care Rep 2013; 2 (02) 109-117
    CrossrefPubMedSearch in Google Scholar
  • 41 Stodghill JD, Collins DT, Mahajan AK, Khandhar SJ. Primary spontaneous pneumothorax: A pathway to practice. AME Med J 2019;4(08). Accessed October 8, 2021: https://amj.amegroups.com/article/view/4806
    PubMed
  • 42 Vuong NL, Elshafay A, Thao LP. et al. Efficacy of treatments in primary spontaneous pneumothorax: A systematic review and network meta-analysis of randomized clinical trials. Respir Med 2018; 137: 152-166
    CrossrefPubMedSearch in Google Scholar
  • 43 How CH, Hsu HH, Chen JS. Chemical pleurodesis for spontaneous pneumothorax. J Formos Med Assoc 2013; 112 (12) 749-755
    CrossrefPubMedSearch in Google Scholar
  • 44 Gupta D, Hansell A, Nichols T, Duong T, Ayres JG, Strachan D. Epidemiology of pneumothorax in England. Thorax 2000; 55 (08) 666-671
    CrossrefPubMedSearch in Google Scholar
  • 45 Bobbio A, Dechartres A, Bouam S. et al. Epidemiology of spontaneous pneumothorax: gender-related differences. Thorax 2015; 70 (07) 653-658
    CrossrefPubMedSearch in Google Scholar
  • 46 MacDuff A, Arnold A, Harvey J. BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. Thorax 2010; 65 (Suppl. 02) ii18-ii31
    CrossrefPubMedSearch in Google Scholar
  • 47 Baumann MH, Strange C, Heffner JE. et al; AACP Pneumothorax Consensus Group. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001; 119 (02) 590-602
    CrossrefPubMedSearch in Google Scholar
  • 48 Walker SP, Bibby AC, Halford P, Stadon L, White P, Maskell NA. Recurrence rates in primary spontaneous pneumothorax: a systematic review and meta-analysis. Eur Respir J 2018; 52 (03) 1800864
    CrossrefPubMedSearch in Google Scholar
  • 49 Alayouty HD, Hasan TM, Alhadad ZA, Omar Barabba R. Mechanical versus chemical pleurodesis for management of primary spontaneous pneumothorax evaluated with thoracic echography. Interact Cardiovasc Thorac Surg 2011; 13 (05) 475-479
    CrossrefPubMedSearch in Google Scholar
  • 50 Joshi V, Kirmani B, Zacharias J. Thoracotomy versus VATS: is there an optimal approach to treating pneumothorax?. Ann R Coll Surg Engl 2013; 95 (01) 61-64
    CrossrefPubMedSearch in Google Scholar
  • 51 Hallifax RJ, Yousuf A, Jones HE, Corcoran JP, Psallidas I, Rahman NM. Effectiveness of chemical pleurodesis in spontaneous pneumothorax recurrence prevention: a systematic review. Thorax 2017; 72 (12) 1121-1131
    CrossrefPubMedSearch in Google Scholar
  • 52 Barker A, Maratos EC, Edmonds L, Lim E. Recurrence rates of video-assisted thoracoscopic versus open surgery in the prevention of recurrent pneumothoraces: a systematic review of randomised and non-randomised trials. Lancet 2007; 370 (9584): 329-335
    CrossrefPubMedSearch in Google Scholar
  • 53 Heffner JE, Huggins JT. Management of secondary spontaneous pneumothorax: there's confusion in the air. Chest 2004; 125 (04) 1190-1192
    CrossrefPubMedSearch in Google Scholar
  • 54 Xia H, Wang XJ, Zhou Q, Shi HZ, Tong ZH. Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. PLoS One 2014; 9 (01) e87060
    CrossrefPubMedSearch in Google Scholar
  • 55 Beltsios ET, Mavrovounis G, Adamou A, Panagiotopoulos N. Talc pleurodesis in malignant pleural effusion: a systematic review and meta-analysis. Gen Thorac Cardiovasc Surg 2021; 69 (05) 832-842
    CrossrefPubMedSearch in Google Scholar
  • 56 Zimmer PW, Hill M, Casey K, Harvey E, Low DE. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997; 112 (02) 430-434
    CrossrefPubMedSearch in Google Scholar
  • 57 Light RW, O'Hara VS, Moritz TE. et al. Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study. JAMA 1990; 264 (17) 2224-2230
    CrossrefPubMedSearch in Google Scholar
  • 58 Hurewitz AN, Lidonicci K, Wu CL, Reim D, Zucker S. Histologic changes of doxycycline pleurodesis in rabbits. Effect of concentration and pH. Chest 1994; 106 (04) 1241-1245
    Search in Google Scholar
  • 59 Vargas FS, Wang NS, Lee HM, Gruer SE, Sassoon CS, Light RW. Effectiveness of bleomycin in comparison to tetracycline as pleural sclerosing agent in rabbits. Chest 1993; 104 (05) 1582-1584
    CrossrefPubMedSearch in Google Scholar
  • 60 Wooten SA, Barbarash RA, Strange C, Sahn SA. Systemic absorption of tetracycline and lidocaine following intrapleural instillation. Chest 1988; 94 (05) 960-963
    CrossrefPubMedSearch in Google Scholar
  • 61 Smythe WR, Bavaria JE. Tetracycline pleurodesis–associated acute renal failure. Chest 1993; 104 (04) 1274-1276
    CrossrefPubMedSearch in Google Scholar
  • 62 Robinson LA, Fleming WH, Galbraith TA. Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg 1993; 55 (05) 1115-1121 , discussion 1121–1122
    CrossrefPubMedSearch in Google Scholar
  • 63 Song KS, Keum D, Kim JB. Chemical Pleurodesis Using Doxycycline and Viscum album Extract. Korean J Thorac Cardiovasc Surg 2017; 50 (04) 281-286
    CrossrefPubMedSearch in Google Scholar
  • 64 Mitchem RE, Herndon BL, Fiorella RM, Molteni A, Battie CN, Reisz GR. Pleurodesis by autologous blood, doxycycline, and talc in a rabbit model. Ann Thorac Surg 1999; 67 (04) 917-921
    CrossrefPubMedSearch in Google Scholar
  • 65 Matin TN, Gleeson FV. Interventional radiology of pleural diseases. Respirology 2011; 16 (03) 419-429
    CrossrefPubMedSearch in Google Scholar
  • 66 Kandarpa K, Machan L, Durham J. Handbook of Interventional Radiologic Procedures. Lippincott Williams & Wilkins; 2016
    Search in Google Scholar
  • 67 Corcoran JP, Hallifax RJ, Mercer RM. et al. Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion. Chest 2018; 154 (05) 1115-1120
    CrossrefPubMedSearch in Google Scholar
  • 68 Feller-Kopman D, Berkowitz D, Boiselle P, Ernst A. Large-volume thoracentesis and the risk of reexpansion pulmonary edema. Ann Thorac Surg 2007; 84 (05) 1656-1661
    CrossrefPubMedSearch in Google Scholar
  • 69 Grogan DR, Irwin RS, Channick R. et al. Complications associated with thoracentesis. A prospective, randomized study comparing three different methods. Arch Intern Med 1990; 150 (04) 873-877
    CrossrefPubMedSearch in Google Scholar
  • 70 Miller KS, Sahn SA. Chest tubes. Indications, technique, management and complications. Chest 1987; 91 (02) 258-264
    CrossrefPubMedSearch in Google Scholar
  • 71 Mercaldi CJ, Lanes SF. Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis. Chest 2013; 143 (02) 532-538
    CrossrefPubMedSearch in Google Scholar
  • 72 Ahmed O, Zangan S. Emergent management of empyema. Semin Intervent Radiol 2012; 29 (03) 226-230
    Thieme ConnectPubMedSearch in Google Scholar
  • 73 Valji K. The Practice of Interventional Radiology, with Online Cases and Video E-Book: Expert Consult Premium Edition - Enhanced Online Features. Elsevier Health Sciences; 2011
    Search in Google Scholar
  • 74 Thornton RH, Miller Z, Covey AM. et al. Tunneled pleural catheters for treatment of recurrent malignant pleural effusion following failed pleurodesis. J Vasc Interv Radiol 2010; 21 (05) 696-700
    CrossrefPubMedSearch in Google Scholar
  • 75 Marquette CH, Marx A, Leroy S. et al; Pneumothorax Study Group. Simplified stepwise management of primary spontaneous pneumothorax: a pilot study. Eur Respir J 2006; 27 (03) 470-476
    CrossrefPubMedSearch in Google Scholar
  • 76 Watanabe T, Fukai I, Okuda K. et al. Talc pleurodesis for secondary pneumothorax in elderly patients with persistent air leak. J Thorac Dis 2019; 11 (01) 171-176
    CrossrefPubMedSearch in Google Scholar
  • 77 Faiz SA, Pathania P, Song J. et al. Indwelling Pleural Catheters for Patients with Hematologic Malignancies. A 14-Year, Single-Center Experience. Ann Am Thorac Soc 2017; 14 (06) 976-985
    CrossrefPubMedSearch in Google Scholar
  • 78 Rahman NM, Pepperell J, Rehal S. et al. Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial. JAMA 2015; 314 (24) 2641-2653
    CrossrefPubMedSearch in Google Scholar
  • 79 Hunt I, Teh E, Southon R, Treasure T. Using non-steroidal anti-inflammatory drugs (NSAIDs) following pleurodesis. Interact Cardiovasc Thorac Surg 2007; 6 (01) 102-104
    CrossrefPubMedSearch in Google Scholar
  • 80 Fysh ETH, Tremblay A, Feller-Kopman D. et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest 2013; 144 (05) 1597-1602
    CrossrefPubMedSearch in Google Scholar
  • 81 Heidecker J, Huggins JT, Sahn SA, Doelken P. Pathophysiology of pneumothorax following ultrasound-guided thoracentesis. Chest 2006; 130 (04) 1173-1184
    CrossrefPubMedSearch in Google Scholar
  • 82 Wrightson JM, Fysh E, Maskell NA, Lee YCG. Risk reduction in pleural procedures: sonography, simulation and supervision. Curr Opin Pulm Med 2010; 16 (04) 340-350
    CrossrefPubMedSearch in Google Scholar
  • 83 Tan C, Tien M, Lee CP. Talc pleurodesis: It's not for everyone. Eur Respir J 2016; 48 (Suppl. 60)
    CrossrefPubMedSearch in Google Scholar
  • 84 Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology 2001; 6 (03) 181-185
    CrossrefPubMedSearch in Google Scholar
  • 85 Fortin M, Tremblay A. Pleural controversies: indwelling pleural catheter vs. pleurodesis for malignant pleural effusions. J Thorac Dis 2015; 7 (06) 1052-1057
    CrossrefPubMedSearch in Google Scholar
  • 86 Ukale V, Agrenius V, Widström O, Hassan A, Hillerdal G. Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive value. Respir Med 2004; 98 (12) 1166-1172
    CrossrefPubMedSearch in Google Scholar
  • 87 Koegelenberg CFN, Shaw JA, Irusen EM, Lee YCG. Contemporary best practice in the management of malignant pleural effusion. Ther Adv Respir Dis 2018; 12: 17 53466618785098
    CrossrefPubMedSearch in Google Scholar
  • 88 Janssen JP, Collier G, Astoul P. et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007; 369 (9572): 1535-1539
    CrossrefPubMedSearch in Google Scholar
  • 89 Montes-Worboys A, Rodriguez-Portal JA, Arellano-Orden E, Digón-Pereiras J, Rodriguez-Panadero F. Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis. Eur Respir J 2010; 35 (01) 160-166
    CrossrefPubMedSearch in Google Scholar
  • 90 Davies CW, Traill ZC, Gleeson FV, Davies RJ. Intrapleural streptokinase in the management of malignant multiloculated pleural effusions. Chest 1999; 115 (03) 729-733
    CrossrefPubMedSearch in Google Scholar